Aktiesnakken — December 2011
-
Som om kliniske forsøg ikke var risikable nok
-
-
Så skal raterne vist noget længere ned..
-
Altså det er jo Ta med hovedet under armen
-
Den ville i givet fald måske yielder 50% i udbytte.....
-
Og den ville blive handlet 4-5 gange under cashbeholdning
-
Ja, man kigger vist bort fra det fundamentale..
-
Det nytter jo ikke noget...
-
-
Karbold koppen vinder den der har den største stigning på ugebasis
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind